Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Oct 6, 2020

Keywords

ClinConnect Summary

The COVITRA Study is a clinical trial that aims to understand how COVID-19 affects people who have received organ transplants. Researchers will look at over 3,000 transplant patients to find out what factors might make them more or less likely to get infected with the virus that causes COVID-19. They will also explore how severe the disease can be in these patients and whether they develop antibodies, which are proteins that help fight infections, after being infected. This study will help determine if these antibodies can show if someone has had the virus before and how long they last in the body.

To be eligible for this study, participants must be adults aged 18 or older who have received a solid organ transplant or a type of stem cell transplant at UZ Leuven and are willing to give their consent to participate. Those who join can expect to contribute to important research that may improve understanding and treatment of COVID-19 in transplant recipients. This study is currently recruiting participants, and everyone is welcome regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients who underwent solid organ or hematopoietic cell transplantation at UZ Leuven and who give informed consent
• Exclusion Criteria:
• • age under 18 years